We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Q2

News List

Future Prospects of Small Molecule and Monoclonal Antibody Drugs in Oncology and Immunology Krebs Qin
October 18, 2024
Specifically, there is a balance between small molecules and monoclonal antibody drugs (mAbs) in the realm of oncology super blockbuster drugs, while immunology appears dominated by monoclonal antibodies and protein-based treatments.
GSK reports £8.1 billion in Q2 sales europeanpharmaceuticalreview
August 04, 2021
GSK announces “excellent” Q2 financial performance with growth across all segments – Pharmaceuticals, Vaccines, Consumer Healthcare.
GC Pharma Reports Q2 2019 Results prnasia
August 06, 2019
GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months ended June 30, 2019.
Novo Nordisk sees revenues drop in Q2 pharmatimes
August 09, 2018
Novo Nordisk saw revenues drop 4% in the second quarter as the diabetes segment stumbled, but reported solid performance for some of its key brands.